Detalles de la búsqueda
1.
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Oncologist
; 29(5): 431-440, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109296
2.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37424386
3.
Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.
Oncologist
; 28(8): e653-e668, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37159001
4.
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
Lancet Oncol
; 23(1): 53-64, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838156
5.
Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study.
BMC Cancer
; 22(1): 941, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050628
6.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147669
7.
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.
Oncologist
; 25(3): e578-e588, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162796
8.
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.
Oncologist
; 24(2): 259-265, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29959285
9.
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
J Neurooncol
; 136(1): 135-145, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29039075
10.
Focused Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for Brain Tumor Patients.
Cancers (Basel)
; 16(8)2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672658
11.
Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Clin Nucl Med
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768063
12.
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?
Clin Nucl Med
; 49(2): 138-145, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113329
13.
FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases.
BMC Cancer
; 13: 491, 2013 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24148527
14.
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Nat Med
; 29(5): 1103-1112, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059834
15.
Complications, compliance, and undertreatment do not explain the relationship between cognition and survival in diffuse glioma patients.
Neurooncol Pract
; 9(4): 284-298, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35855455
16.
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma.
Clin Cancer Res
; 28(14): 3002-3010, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294522
17.
Attitudes Toward Striving for Quality and Length of Life Among Patients With Advanced Cancer and a Poor Prognosis.
JCO Oncol Pract
; 18(11): e1818-e1830, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201709
18.
Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma.
Front Neurol
; 12: 773908, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34867763
19.
Cognitive impairments are independently associated with shorter survival in diffuse glioma patients.
J Neurol
; 268(4): 1434-1442, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211158
20.
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma.
Eur J Cancer
; 147: 1-12, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33601293